FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Northern VA Compounders PLLC TriMix Plus 002 Recall

TriMix Plus 002 (PGE1/Papaverine HCl/Phentolamine Mesylante) 25mcg/30mg/2mg/mL INJECTAB…

Northern VA Compounders PLLC · Sterling, VA

Risk level
Class II
Reported by FDA
Jan 18, 2023
Recall ID
D-0123-2023
Check your lot numberHow we source this data

Summary

Northern VA Compounders PLLC recalled TriMix Plus 002 starting Dec 30, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0123-2023 on Jan 18, 2023. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

TriMix Plus 002 (PGE1/Papaverine HCl/Phentolamine Mesylante) 25mcg/30mg/2mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.

Lot numbers, UPCs & expiration codes

Lot#: 12062022@4, Exp 1/20/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0123-2023
Classification
Class II
Status
Terminated
Recall initiated
Dec 30, 2022
FDA report date
Jan 18, 2023
Quantity
36 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Northern VA Compounders PLLC

Original FDA data

Every field from FDA enforcement report D-0123-2023, exactly as published.

Show all FDA fields
City
Sterling
State
VA
Status
Terminated
Country
United States
Event ID
91443
Address
23475 Rock Haven Way
Address (line 2)
Suite 105
Code information
Lot#: 12062022@4, Exp 1/20/2023
Postal code
20166-4444
Report date
Jan 18, 2023
Product type
Drugs
Recall number
D-0123-2023
Classification
Class II
Recalling firm
Northern VA Compounders PLLC
Product quantity
36 vials
Termination date
Jun 21, 2023
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
TriMix Plus 002 (PGE1/Papaverine HCl/Phentolamine Mesylante) 25mcg/30mg/2mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 30, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jan 12, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0123-2023, published Jan 18, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls